Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

Authors

Mireia Toledano‐Pinedo

Published

September 10, 2024

Abstract

Herein, we describe the design, synthesis, and biological evaluation of 15

Supporters

Support the authors with ResearchCoin

Journal

Journal of Medicinal Chemistry

Topics

DOI

10.1021/acs.jmedchem.4c01367

Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

Authors

Mireia Toledano‐Pinedo

Published

September 10, 2024

Abstract

Herein, we describe the design, synthesis, and biological evaluation of 15

Supporters

Support the authors with ResearchCoin

Journal

Journal of Medicinal Chemistry

Topics

DOI

10.1021/acs.jmedchem.4c01367

Paper

Paper

Paper

Paper

Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

Abstract

Supporters

Journal

Topics

DOI

Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

Abstract

Supporters

Journal

Topics

DOI